Stay updated with breaking news from Eric Elenko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) COO Andrew Craig Miller sold 30,000 shares of the firm’s stock in a transaction dated Tuesday, April 18th. The shares were sold at an average price of $200.16, for a total value of $6,004,800.00. Following the transaction, the chief operating officer now owns 30,900 shares of the company’s […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 2,140,000 shares, a growth of 22.3% from the March 15th total of 1,750,000 shares. Based on an average daily volume of 389,900 shares, the days-to-cover ratio is […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) Director Laurie J. Olson sold 1,000 shares of the firm’s stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $181.02, for a total value of $181,020.00. The transaction was disclosed in a legal filing with the SEC, which is accessible […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) Director Laurie J. Olson sold 1,000 shares of the company’s stock in a transaction dated Monday, April 3rd. The shares were sold at an average price of $181.02, for a total value of $181,020.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which […]
Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the sixteen analysts that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 12 […]